Atlas Trials

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

Clinical trial NCT04316169 · WITHDRAWN

Trial details

NCT number
NCT04316169
Sponsor
Medical College of Wisconsin
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Solid TumorAdvanced Breast Cancer
Start date
2021-10-21
Primary completion
2027-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.